Novartis wins US OK for biosimilar version of Amgen's Enbrel
Tuesday, August 30, 2016 - 16:31
in Health & Medicine
U.S. regulators have approved the first near-copy of Enbrel, drugmaker Amgen's pricey biologic medicine for treating rheumatoid arthritis and other immune system disorders....